Landscape Capital Management’s Tenax Therapeutics TENX Stock Holding History

Landscape Capital Management’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.92M	Buy	+132,272	New	+$1.69M	0.12%	273

Other funds holding TENX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Landscape Capital Management's TENX Position: Q2 2026 in Review

Landscape Capital Management opened a new position in Tenax Therapeutics (TENX) in Q2 2026: 132,272 shares worth $1.92M. The stake represents 0.12% of the portfolio and ranks #273 among its holdings.

30 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

Landscape Capital Management held 132,272 shares of Tenax Therapeutics worth $1.92M as of Q2 2026.
Tenax Therapeutics was a new Landscape Capital Management position in Q2 2026.
Tenax Therapeutics made up 0.12% of Landscape Capital Management's portfolio in Q2 2026, its #273 holding.
30 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.